NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Series GSE268371 Query DataSets for GSE268371
Status Public on Jun 25, 2024
Title Precise RNA knockdown of smn1,or tardbp and tarbpl by CRISPR-QKD and transcription activation of lin28a and sox9b by CRISPR-Qa in zebrafish
Organism Danio rerio
Experiment type Expression profiling by high throughput sequencing
Summary CRISPR-Cas systems have revolutionized gene regulation technologies in various organisms, including zebrafish. However, most zebrafish studies rely on transient injections of CRISPR components, with limited use of transgenic models, primarily for Cas9-mediated knockouts. This is largely due to challenges in achieving sustained and effective expression of Cas effectors. To address these challenges, we introduce the CRISPR-Q system, which integrates the QFvpr/QUAS binary expression system with CRISPR-Cas effectors. This approach overcomes limitations associated with transient mRNA or protein delivery and circumvents the toxicity and silencing issues typical of other binary systems, such as Gal4/UAS. The CRISPR-Q system enables robust expression of CasRx or dCas9vpr, facilitating efficient transcript knockdown (CRISPR-QKD) and gene activation (CRISPR-Qa). Using this system, we successfully achieved significant knockdown of smn1 and the simultaneous knockdown of the paralogs tardbp and tardbpl, modeling phenotypes of spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS), respectively. Furthermore, CRISPR-Qa effectively activated the endogenous genes lin28a and sox9b, demonstrating the system's broad applicability. The CRISPR-Q system represents a significant advancement in zebrafish genetic manipulation, providing a robust and versatile platform for studying gene function and modeling human diseases, with potential extensions to other model organisms
 
Overall design To investigate the efficiency and specificity of CRISPR-Q induced KD or transcriptional activation, we established triple transgenic (3Tg) zebrafish which contains CRISPR-Q components and guide RNAs (gRNAs or sgRNAs), and double transgenic (2Tg) zebrafish which lacks gRNA, served as a control. gRNA targeting smn1 and gRNA array targeting tardbp and tardbpl were used to test CRISPR-QKD, while sgRNAs targeting lin28a and sox9b were used for CRISPR-Qa. We then performed RNA-seq analysis for smn1, tardbp, lin28a and sox9b from 3Tg embryos and their respective 2Tg siblings.
 
Contributor(s) Jin YN, Shi M, Ge W, Bin L, Deng X, Liu C, Zheng M, Zhang P, Lei L, Li C, Guo Y, Yu YV
Citation missing Has this study been published? Please login to update or notify GEO.
Submission date May 26, 2024
Last update date Jun 25, 2024
Contact name Youngnam N Jin
E-mail(s) ynjin.neo@gmail.com
Phone 13628627281
Organization name Wuhan University
Department Medical Research Institute
Street address 115 Donghu Road, Wuchang District
City Wuhan
State/province Hubei
ZIP/Postal code 430071
Country China
 
Platforms (1)
GPL24995 Illumina NovaSeq 6000 (Danio rerio)
Samples (24)
GSM8290343 smn1.2TG, rep1
GSM8290344 smn1, 2TG, rep2
GSM8290345 smn1, 2TG, rep3
Relations
BioProject PRJNA1116733

Download family Format
SOFT formatted family file(s) SOFTHelp
MINiML formatted family file(s) MINiMLHelp
Series Matrix File(s) TXTHelp

Supplementary file Size Download File type/resource
GSE268371_salmon.merged.gene.tpm_lin28a-Tg.xlsx 3.4 Mb (ftp)(http) XLSX
GSE268371_salmon.merged.gene.tpm_smn1-Tg.xlsx 3.1 Mb (ftp)(http) XLSX
GSE268371_salmon.merged.gene.tpm_sox9b-Tg.xlsx 2.0 Mb (ftp)(http) XLSX
GSE268371_salmon.merged.gene.tpm_tardbp-Tg.xlsx 3.5 Mb (ftp)(http) XLSX
SRA Run SelectorHelp
Raw data are available in SRA

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap